FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
40.61 EUR
-0.1 (-0.25%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. FME has only an average score on both its financial health and profitability. FME has a decent growth rate and is not valued too expensively. Finally FME also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
FME had positive earnings in the past year.
FME had a positive operating cash flow in the past year.
FME had positive earnings in each of the past 5 years.
FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FME has a Return On Assets (2.33%) which is in line with its industry peers.
The Return On Equity of FME (5.55%) is worse than 60.71% of its industry peers.
The Return On Invested Capital of FME (3.95%) is worse than 60.71% of its industry peers.
FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.91%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME has a better Profit Margin (3.66%) than 60.71% of its industry peers.
FME's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.19%, FME is in line with its industry, outperforming 53.57% of the companies in the same industry.
In the last couple of years the Operating Margin of FME has declined.
FME has a Gross Margin (25.00%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FME has about the same amount of shares outstanding.
Compared to 5 years ago, FME has less shares outstanding
The debt/assets ratio for FME has been reduced compared to a year ago.
2.2 Solvency
FME has an Altman-Z score of 2.20. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
FME has a Altman-Z score (2.20) which is in line with its industry peers.
The Debt to FCF ratio of FME is 5.97, which is a neutral value as it means it would take FME, 5.97 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of FME (5.97) is better than 75.00% of its industry peers.
FME has a Debt/Equity ratio of 0.73. This is a neutral value indicating FME is somewhat dependend on debt financing.
The Debt to Equity ratio of FME (0.73) is better than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.7
WACC5.68%
2.3 Liquidity
FME has a Current Ratio of 1.36. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
FME has a better Current ratio (1.36) than 67.86% of its industry peers.
A Quick Ratio of 1.00 indicates that FME may have some problems paying its short term obligations.
With a decent Quick ratio value of 1.00, FME is doing good in the industry, outperforming 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.77% over the past year.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
The Earnings Per Share is expected to grow by 13.73% on average over the next years. This is quite good.
Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.80, the valuation of FME can be described as reasonable.
Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 89.29% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.84. FME is valued rather cheaply when compared to this.
FME is valuated reasonably with a Price/Forward Earnings ratio of 9.79.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.8 | ||
| Fwd PE | 9.79 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FME is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
FME's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.58 | ||
| EV/EBITDA | 10.56 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.54%. Purely for dividend investing, there may be better candidates out there.
FME's Dividend Yield is rather good when compared to the industry average which is at 1.47. FME pays more dividend than 96.43% of the companies in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
FME pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FRA:FME (12/29/2025, 7:00:00 PM)
40.61
-0.1 (-0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.83B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target47.6 (17.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-5.83%
EPS NQ rev (1m)2.05%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)2.83%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.8 | ||
| Fwd PE | 9.79 | ||
| P/S | 1.21 | ||
| P/FCF | 13.58 | ||
| P/OCF | 9.49 | ||
| P/B | 1.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.56 |
EPS(TTM)3.76
EY9.26%
EPS(NY)4.15
Fwd EY10.21%
FCF(TTM)2.99
FCFY7.36%
OCF(TTM)4.28
OCFY10.54%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.5
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.68%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.8 and the Price/Book (PB) ratio is 1.84.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.